Back to Journals » Drug Design, Development and Therapy » Volume 11
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Safety and efficacy of the addition of pertuzumab to T-DM1 ± taxane in patients with HER2-positive, locally advanced or metastatic breast cancer: a pooled analysis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,332 | Dovepress* | 8,413+ | 1,041 | 9,454 | |
PubMed Central* | 919 | 318 | 1,237 | ||
Totals | 9,332 | 1,359 | 10,691 | ||
*Since 15 November 2017 |
View citations on PubMed Central and Google Scholar